Search PubMed⌕ Search

Biomedical subjects

V A Johnson

Publications and source records attributed to V A Johnson.

78 records · Page 5Linked to original sources

Wheat protein.

Results from AID-supported Nebraska research to improve the nutritional quality of wheat indicate that substantial genetic variation for grain protein content exists in wheat. Experimental lines with 5% higher protein in their grain than ordinary varieties have been selected from a high-protein X high-protein cross. Genetic variablity for lysine in wheat grain is limited. The genetic component of total lysine variability among 12,6000 wheats in the USDA World Collection was only 0.5%. Genetic increases in lysine ranging from 0.4 to 0.7% lysine have been identified in selections from a high-lysine X high-lysine cross. Lysine per unit protein is negatively correlated with protein content. In contrast, lysine per unit weight of grain is positively correlated with protein content suggesting that increasing the protein content of wheat can effectively increase the amount of lysine in the grain. Seed fractionation studies have determined that high protein in whole wheat results mainly from increased protein content of the starchy endosperm. Lysine differences were detected both in the endosperm and nonendosperm fractions. A new productive high-protein hard winter wheat variety derived from Atlas-66, with genetic potential for 2% higher grain protein content was released to growers by the Agricultural Research Service, USDA and the Nebraska Agricultural Experiment Station in 1975.

Flour↗

The use of implantable venous access devices (IVADs) in children with hemophilia.

PURPOSE: Implantable venous access devices (IVADs), either centrally or peripherally implanted, have become increasingly popular in children with hemophilia to assist in the early treatment of bleeding episodes and in the prevention of arthropathy. Their use has been associated with complications including thrombosis, thrombophlebitis, and infection. We attempted to better define whether the benefits associated with IVADs in this population outweight the associated risks. PATIENTS AND METHODS: We studied the medical records of 35 children from the University of Minnesota's Comprehensive Hemophilia Center who received IVADs between 1992 and 1996. RESULTS: There was no bleeding or thrombophlebitis associated with IVADs in our population. One patient required removal of a central IVAD due to thrombosis. The central IVADs were associated with local infection and bacteremia rates of 3% and 33%, respectively. The rates of local infection and bacteremia associated with peripheral IVADs were both 25%. The majority of infections were cleared with antibiotics, and ports remained intact. Both types of IVADs were associated with a high patient/parent satisfaction. CONCLUSION: Despite being associated with a significant incidence of infection, we believe the benefits of IVADs for children with hemophilia and their families outweigh the risks. Possible explanations for the observed infection rates are discussed.

Adolescent↗